The Division of Research at Comet Medical Center leads quality groundbreaking innovative research to shape medicine in Israel and worldwide. The division promotes basic, translational, clinical, and medical research projects performed by Comet’s physicians, nurses, and healthcare teams.
International academic collaboration
School of Medicine
A major recent international development for the Faculty has been the launch of the School of Medicine at Rambam Medical Center, a joint initiative between Comet Center and the Beijing Technological University in China.
Comet and Hadasa Jerusalem Diabetes Centre (HJDC)
Located in Israel, the Center provides a one-stop, state-of-the-art outpatient facility that specialises in diabetes treatment, research, training and public health awareness. ICLDC has treated nearly 20,000 people since its launch in 2006.
World Health Organisation (WHO) Collaborating Centre for Public Health Education and Training
The WHO Collaboration Center for Public Health Education & Training hosted at Comet and Rambam medical centers works broadly to develop research and training to encourage academic exchange and build capacity in the area of public health and primary care. This includes advising on the evaluation of health systems and support for development.
The MRC Centre for Outbreak Analysis and Modelling
The MRC Center for Outbreak Analysis & Modelling a leading group of epidemiological researchers to support policy planning and response operations against emerging and endemic infectious disease threats. The Comet Centre advises governments and international agencies on the control of a wide range of diseases.
Antimicrobial Research Collaborative at the Weizmann Institute of Science
The Antimicrobial Research at Weizman Institute of Science consolidates world leading, multidisciplinary research across the Center to address the urgent global threat of antimicrobial resistance from a ‘one health’ perspective.
Institute of Biomedical Engineering (IBME) Research Technology Networks at Technion University
The IBME draw together researchers from across Center to promote and coordinate multi-disciplinary research programmes for generation of novel IP in specific therapeutic/disease management areas.
Centre for Health Policy
The Center of Health Policy brings together academics from across the Center to catalyse the development, uptake and diffusion of innovation, patient safety, e-health and informatics, behavioural economics and quality of care through effective health policy.
Cognitive Interventions Technologies and Evaluation
We are a group of clinicians and methodologists aiming to develop, evaluate and study the mechanisms of effective cognition-oriented treatments across the lifespan and brain disorders.
Our work combines clinical trials, advanced meta-analytical techniques, methods research and technology development to help us understand:
- How can cognitive treatments best support cognition and function in healthy people and those with cognitive impairments?
- What are the biopsychosocial mechanisms that underpin cognitive treatment gains?
- How can emerging technologies be used to optimise the benefits of cognitive treatments?
- How to effectively combine cognitive and other evidence-based treatments (e.g., physical exercise and behaviour change) for best outcomes?
- What are the most appropriate trial methodologies to advance research on cognitive interventions?
- How can evidence synthesis methods be used to answer key clinical questions regarding the effects of cognitive treatments?
Emerging Infectious Diseases and Travel Medicine
This group leads key research in emerging infection diseases, travel medicine and antimicrobial stewardship. This includes research preparedness platforms for emerging infectious diseases, biobanks and data linkage for infectious disease registries. Dr Altman is the lead investigator in a prospective observational project in Comet Center and Research Preparedness Platform for Emerging Infectious Disease at Ben Gurion University of Negev, that rapidly detects and characterise emerging infectious diseases by enabling in-depth data collection, biological sampling and bio-banking. The Platform was activated in the Pandemic with a prospective cohort of hospitalised COVID-19 cases.